Health Technology Innovations, Inc

Supercharging drug discovery with AI/ML software platform for cryo-electron microscopy and structure-based drug discovery

  • Stage $1M in TTM Revenue
  • Industry Artificial Intelligence
  • Location Portland, OR, USA
  • Currency USD
  • Founded April 2019
  • Employees 8
  • Incorporation Type C-corp
  • Website hti.ai

Company Summary

Provide AI software & services to help Pharma cut drug discovery time in half. Uniquely combining two cutting-edge technologies; Cryo-EM allows scientists to determine molecular structures at atomic resolution to enable structure-based drug discovery (SBDD). AI improves the efficiency of Cryo-EM and can be used to identify and prioritize lead compounds.
Addressing an $8B market by licensing software with $1.8M revenue today and $26M by 2029.

Team

  • Tuan Phamdo
    CEO

    Lead strategy and execution. Launched the Cancer Cloud Collaborative initiative with OHSU and two major cancer institutions. Solid expertise in program management, product marketing, and engineering management. Lead Intel Data Center Global Pathfinding Operation with $50 million per year in global operations and strategic alliances. Intel Vietnam General Manager with overall revenue responsibility.

Advisors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free